Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer
Eur Urol Oncol 2021 Dec 28;[EPub Ahead of Print], R Hannan, M Christensen, H Hammers, A Christie, B Paulman, D Lin, A Garant, W Arafat, K Courtney, I Bowman, S Cole, D Sher, C Ahn, H Choy, R Timmerman, J BrugarolasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.